Skip to content
News
Nasodine® Throat Spray  launches in Singapore

Nasodine® Throat Spray launches in Singapore


Firebrick Pharma (ASX:FRE) is very pleased to announce that its new product – Nasodine® Throat Spray – has been launched in Singapore. This follows successful completion of commercial manufacturing in Australia in November and December 2025, and shipment to Singapore in early January 2026. Nasodine Throat Spray is a 1% povidone-iodine solution designed for oral…

Firebrick announces new product: Nasodine® Throat Spray

Firebrick announces new product: Nasodine® Throat Spray


Firebrick Pharma (ASX:FRE) is pleased to announce that it has commenced manufacture of Nasodine® Throat Spray for export in November 2025, which will be the first new product in the Nasodine range since Nasodine Nasal Spray, which was launched in Singapore in 2024. Nasodine Throat Spray is a 1.0% povidone-iodine formulation for treatment of sore…